ClinicalTrials.gov
public full text
Public Domain
CyberKnife for Prostate Cancer Patients Aged 70 y or More
Robotic Stereotactic Radiation treatment of prostatic adenocarcinoma of the elderly. Inclusion criteria : T1-T3b, MRI pelvic nodes negative, M0, any Gleason Score, PSA (Prostate Specific Antigen) \5. Primary objective : acute and late toxicity evaluation at 36 months. Secondary objectives : PSA and MRI response.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CyberKnife Radiosurgery for Localized Prostatic Carcinoma#867416
- CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry#824854
- Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)#890537
- CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer#1058425
- CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer#837353
Record · ID 902929
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive